Novavax, Inc.
Novavax is a biotechnology company developing vaccines, with its primary political signal being exposure to 8 healthcare bills with an estimated revenue impact of $16.2M each.
BusinessWhat NVAX does
Novavax, Inc. is a biotechnology company focused on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its revenue is primarily derived from its protein-based COVID-19 vaccine and its pipeline of vaccine candidates for influenza and other respiratory viruses.
12 months past · 3 months futureNVAX activity timeline
Lifetime Government AwardsNVAX federal contracts
NVAX doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Congressional TradesWho in Congress is trading NVAX
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting NVAXLive legislation impacting this stock
Political ProfileWhere NVAX sits in Washington
[object Object]
STRUCTURAL: High regulatory density (85) due to 8 impactful healthcare bills. EVIDENTIARY: No direct political engagement: $0 lobbying (`get_political_influence.lobbying.total_income`), 0 insider buys (`get_corporate_insider_signal.total_buys`), 0 congressional trades (`Top congressional traders`). Net: Pure legislative exposure without supporting political capital.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
High exposure to legislative changes in the healthcare sector.U.S. Congress"`Recent bill_impacts` lists 8 healthcare bills with material estimated revenue impacts."
Regulatory opportunities
-
Potential revenue upside from favorable healthcare legislation.U.S. Congress"`Recent bill_impacts` shows multiple bills with positive estimated revenue impacts, indicating legislative tailwinds."
Live signals + predictions for NVAX — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades NVAX
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord